Abstract
On September 21, 2009, China began administering vaccines, obtained from 10 different manufacturers, against 2009 pandemic influenza A (H1N1) virus infection in priority populations. We aimed to assess the safety of this vaccination program.
Cite
CITATION STYLE
APA
Liang, X.-F., Li, L., Liu, D.-W., Li, K.-L., Wu, W.-D., Zhu, B.-P., … Wang, Y. (2011). Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China. New England Journal of Medicine, 364(7), 638–647. https://doi.org/10.1056/nejmoa1008553
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free